Search for: "APOTEX CORP." Results 201 - 220 of 333
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Mar 2011, 10:07 pm by Jason Rantanen
Microsoft Corp., 374 F.3d 1151, 1157 (Fed. [read post]
16 Mar 2011, 3:50 am by Marie Louise
(Kluwer Patent Blog) US: Abraxis Biosciences v Navinta en banc denied – looking back to DBB, forward to Stanford/Roche (IPBiz) US: W D Washington denies preliminary injunction in biotech trademark dispute: Mirina Corp. v Marina Biotech (Seattle Trademark Lawyer) US: Issues to consider when structuring medical device development and license agreements (IP Spotlight) US: Have you benefited from public access to PubMed? [read post]
26 Feb 2011, 3:47 pm
Wyko Corp., 79 F.3d 1563, 1570 (Fed. [read post]
14 Jan 2011, 10:07 am by Christa Culver
Winstar Corp. (1996), that has been adopted as the test for application of the doctrine by the Federal Circuit? [read post]
29 Dec 2010, 2:57 am by Marie Louise
– FDA again seeking to restrict marketing of unapproved animal drugs (FDA Law Blog) US: Notorious affiliate exclusion provision of PPACA repealed (FDA Law Blog) US: Cephalon’s gambit in pay-to-delay (IPBiz) US: Labcorp’s failed patent re-examination challenge at issue in contract dispute: Lab Corp. of Am. [read post]
21 Dec 2010, 11:36 pm
Apotex Corp., 403 F.3d 1331, 1340-41 (Fed. [read post]
21 Dec 2010, 10:07 am by Lawrence B. Ebert
Apotex Corp., 403 F.3d1331, 1340-41 (Fed. [read post]
5 Nov 2010, 1:38 pm
Apotex Corp., 439 F.3d 1312, 1319 (Fed. [read post]
4 Nov 2010, 10:59 am by Jason Rantanen
” Titan Tire Corp., 566 F.3d at 1376 (citation omitted). [read post]
2 Nov 2010, 1:40 am
Ct. 365, 374 (2008); see also Titan Tire Corp. v. [read post]
13 Oct 2010, 3:14 pm
6,730,817 claims a process for making a refrigerant gas that won't deplete atmospheric ozone and turn Earth into more of a baking oven than humans are busy otherwise doing. [read post]
7 Sep 2010, 6:10 pm by Kelly
(Docket Report) US: Helicos Biosciences Corp files patent infringement suit against Pacific Biosciences of California in response to its manufacture and use of Single Molecule Real Time DNA sequencing technology (Patent Docs) US: Report predicts tough road ahead for some generics after Federal Circuit patent use code decisions (FDA Law Blog) Products Angiomax (Bivalirudin) – US: APP moves forward with appeal notice in Angiomax PTE litigation in light of PTO/FDA indecision: Medicines… [read post]